 |
Quick Links |
| Information by Disease |
|
|
|
| Cancer News |
|
|
|
| Conference Coverage |
|
|
|
| AZN | $46.43 | 0.34 (0.74%)
| | NVS | $59.94 | 1.96 (3.38%)
| | SNY | $36.24 | 0.23 (0.64%)
| | GSK | $47.66 | -1 (-2.06%)
|
|
|
|
|
|
|
 Latest Supportive Care News |
|
|
|
|
|
|
|
|
Conference Coverage |
 |
|
MASCC/ISOO 16th International Supportive Care in Cancer Symposium: Recombinant Human Erythropoietin Products
Lee Schwartzberg, MD FACP New Developments in Anemia Treatment: ASCO 2004
Lee Schwartzberg, M.D., F.A.C.P., The West Clinic ASH 2003 Anemia Review
Author: Lee Schwartzberg MD, FACP The West Clinic Advances in the Management of Anemia and Fatigue (ONS 2003)
Jennifer Maxon, RN Aranesp®: Advances in the Management of Anemia (ASCO 2003)
John Glaspy, MD Chemotherapy-Induced Nausea and Vomiting (CINV): An Update from ASCO 2004
David Ettinger, MD Professor of Oncology and Medicine, Associate Director for Clinical Research in the Oncology Center, Johns Hopkins
MASCC/ISOO 16th International Supportive Care in Cancer Symposium: Clinical Trial Results on the Safety and Efficacy of Aloxi®
C. D. Buckner, Medical Editorial Director, OncoEd
Chemotherapy-Induced Nausea and Vomiting: An Update from ONS 2004
C. D. Buckner, MD and Jennifer Maxon, RN Past, Present and Future of Chemotherapy Induced Nausea and Vomiting (ONS 2003)
Management of Mucositis: ASTRO 2003 Advances in the Treatment of Mucositis: Update from ASH 2003
Advances in the Management of Chemotherapy Induced Neutropenia (ONS 2003)Challenges Facing Pain Management (ONS 2003)
|
|
|
 |
 Current Topics in Oncology |
 |
|
 |
|
Intravenous Iron in the Management of Chemotherapy-Induced Anemia: An Update from ASCO 2007 - CME
Michael Auerbach, MD, Georgetown University School of Medicine, Baltimore, MD Advances in the Treatment of Myelosuppression and Anemia
John Glaspy, MD, Director of Clinical Research Unit Shared Resource, UCLA Medical Center. Classifying and Managing Chemotherapy-Induced Anemia
Charles H. Weaver, MD, and Jenny Maxon, RN. ASH 2007: Supportive Care and Hematologic Malignancies - CME Advances in the Treatment of Myelosuppression and Anemia - CME Classifying and Managing Chemotherapy-Induced Anemia - CME Anemia and the Use of Hematopoietic Growth Factors - CME The Role of Erythropoietic Agents in Managing the Anemia of Cancer Anemia and Gastrointestinal Cancer: Updates from ASCO GI 2007 Main - Refractory Anemia with Excess Blasts in Transformation Main - Refractory Anemia with Excess Blasts Advances in the Prevention and Management of Oral Mucositis
Jennifer Maxon 1 Abstract and Introduction (5/12/2004)
1 Abstract and Introduction (5/12/2004)
1 Neurophysiology of Cancer Pain (5/12/2004)
1 Abstract and Introduction (5/12/2004)
1 Abstract and Introduction (5/12/2004)
|
|
|
 |
|
 |
|
 Supportive Care Drug Pipeline |
|
|
|
|
|
|
|
|
 Newsletters |
|
|
 |
Register in our member center today to receive a monthly newsletter with clinical news, conference coverage, and current topic updates.
Learn More »
|
|
|
|
|
|
|
Information by Cancer Type |
|
|
|
|
|
|
|
|
|
|
Patient Home
